Characterizing complex polysera produced by antigen-specific immunization through the use of affinity-selected mimotopes

PLoS ONE

Volumn 4, Issue 4, 2009, Pages

  Denisova, Galina ^a   Denisov, Dimitri ^a   Evelegh, Carole ^a   Weissgram, Michaela ^a   Beck, Jochen ^a   Foley, Stephen Ronan ^a   Bramson, Jonathan Lorne ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPITOPE; POLYCLONAL ANTIBODY; ANTISERUM; PEPTIDE LIBRARY;

ALGORITHM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; BINDING AFFINITY; BREAST CANCER; CANCER IMMUNIZATION; CELL STRAIN; CHO CELL; COMPUTER ANALYSIS; CONTROLLED STUDY; DRUG TARGETING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MOUSE; NONHUMAN; PLASMID; PREDICTION; PROTO ONCOGENE; RAT; TUMOR GROWTH; VACCINATION; ANIMAL; BAGG ALBINO MOUSE; CELL PROLIFERATION; CHEMISTRY; IMMUNIZATION; IMMUNOLOGY; METABOLISM; TRANSGENIC MOUSE;

ALGORITHMS; ANIMALS; CELL PROLIFERATION; EPITOPES; IMMUNE SERA; IMMUNIZATION; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; PEPTIDE LIBRARY; RATS; RECEPTOR, ERBB-2;

EID: 65349104579     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005309     Document Type: Article

References (41)

1. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, et al. (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707-712.
2. Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, et al. (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344: 783-792.
3. Shak S (1999) Overview of the trastuzumab (Herceptin) anti-HER2 monoclonal antibody clinical program in HER2-overexpressing metastatic breast cancer. Herceptin Multinational Investigator Study Group. Semin Oncol 26: 71-77.
4. Yip YL, Smith G, Koch J, Dubel S, Ward RL (2001) Identification of epitope regions recognized by tumor inhibitory and stimulatory anti-ErbB-2 monoclonal antibodies: implications for vaccine design. J Immunol 166: 5271-5278.
5. Van Regenmortel MHV (1996) Mapping Epitope Structure and Activity: From One-Dimensional Prediction to Four-Dimensional Description of Antigenic Specificity. Methods 9: 465-472.
6. Denisova G, Lideman L, Spectorman E, Abulafia-Lapid R, Burke M, et al. (2003) Characterization of new monoclonal antibodies that discriminate between soluble and membrane CD4 and compete with human anti-CD4 autoimmune sera. Mol Immunol 40: 231-239.
7. Denisova G, Stern B, Raviv D, Zwickel J, Smorodinsky NI, et al. (1996) Humoral immune response to immunocomplexed HIV envelope glycoprotein 120. AIDS Res Hum Retroviruses 12: 901-909.
8. Denisova G, Zwickel J, Gershoni JM (1995) Binding of HIV-1 gp120 to an anti-V3 loop antibody reveals novel antigen-induced epitopes. FASEB J 9: 127-132.
9. Denisova GF, Denisov DA, Yeung J, Loeb MB, Diamond MS, et al. (2008) A novel computer algorithm improves antibody epitope prediction using affinity-selected mimotopes: A case study using monoclonal antibodies against the West Nile virus E protein. Mol Immunol 46: 125-134.
10. Denisova GF, Zerwanitzer M, Denisov DA, Spectorman E, Mondor I, et al. (2000) Expansion of epitope cross-reactivity by anti-idiotype modulation of the primary humoral response. Mol Immunol 37: 53-58.
11. Enshell-Seijffers D, Denisov D, Groisman B, Smelyanski L, Meyuhas R, et al. (2003) The mapping and reconstitution of a conformational discontinuous B-cell epitope of HIV-1. J Mol Biol 334: 87-101.
12. Gershoni JM, Stern B, Denisova G (1997) Combinatorial libraries, epitope structure and the prediction of protein conformations. Immunol Today 18: 108-110.
13. Paley EL, Smelyanski L, Malinovskii V, Subbarayan PR, Berdichevsky Y, et al. (2007) Mapping and molecular characterization of novel monoclonal antibodies to conformational epitopes on NH2 and COOH termini of mammalian tryptophanyl-tRNA synthetase reveal link of the epitopes to aggregation and Alzheimer's disease. Mol Immunol 44: 541-557.
14. Stern B, Denisova G, Buyaner D, Raviv D, Gershoni JM (1997) Helical epitopes determined by low-stringency antibody screening of a combinatorial peptide library. FASEB J 11: 147-153.
15. Denisov DA, Denisova GF, Lelic A, Loeb MB, Bramson JL (2009) Deciphering epitope specificities within polyserum using affinity selection of random peptides and a novel algorithm based on pattern recognition theory. Mol Immunol 46: 429-436.
16. Scott JK, Smith GP (1990) Searching for peptide ligands with an epitope library. Science 249: 386-390.
17. Felici F, Luzzago A, Folgori A, Cortese R (1993) Mimicking of discontinuous epitopes by phage-displayed peptides, II. Selection of clones recognized by a protective monoclonal antibody against the Bordetella pertussis toxin from phage peptide libraries. Gene 128: 21-27.
18. Luzzago A, Felici F, Tramontano A, Pessi A, Cortese R (1993) Mimicking of discontinuous epitopes by phage-displayed peptides, I. Epitope mapping of human H ferritin using a phage library of constrained peptides. Gene 128: 51-57.
19. Chen Y, Emtage P, Zhu Q, Foley R, Muller W, et al. (2001) Induction of ErbB-2/neu-specific protective and therapeutic antitumor immunity using genetically modified dendritic cells: enhanced efficacy by cotransduction of gene encoding IL-12. Gene Ther 8: 316-323.
20. Kianizad K, Marshall LA, Grinshtein N, Bernard D, Margl R, et al. (2007) Elevated frequencies of self-reactive CD8+ T cells following immunization with a xenoantigen are due to the presence of a heteroclitic CD4+ T-cell helper epitope. Cancer Res 67: 6459-6467.
21. Lane C, Leitch J, Tan X, Hadjati J, Bramson JL, et al. (2004) Vaccination-induced autoimmune vitiligo is a consequence of secondary trauma to the skin. Cancer Res 64: 1509-1514.
22. Pupa SM, Iezzi M, Di Carlo E, Invernizzi A, Cavallo F, et al. (2005) Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccination. Cancer Res 65: 1071-1078.
23. Quaglino E, Iezzi M, Mastini C, Amici A, Pericle F, et al. (2004) Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice. Cancer Res 64: 2858-2864.
24. Rovero S, Amici A, Carlo ED, Bei R, Nanni P, et al. (2000) DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice. J Immunol 165: 5133-5142.
25. Zacher AN 3rd, Stock CA, Golden JW 2nd, Smith GP (1980) A new filamentous phage cloning vector: fd-tet. Gene 9: 127-140.
26. Batori V, Friis EP, Nielsen H, Roggen EL (2006) An in silico method using an epitope motif database for predicting the location of antigenic determinants on proteins in a structural context. J Mol Recognit 19: 21-29.
27. Franklin MC, Carey KD, Vajdos FF, Leahy DJ, de Vos AM, et al. (2004) Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex. Cancer Cell 5: 317-328.
28. Hopp TP, Woods KR (1981) Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci U S A 78: 3824-3828.
29. Westhof E, Altschuh D, Moras D, Bloomer AC, Mondragon A, et al. (1984) Correlation between segmental mobility and the location of antigenic determinants in proteins. Nature 311: 123-126.
30. Novotny J, Handschumacher M, Haber E (1986) Location of antigenic epitopes on antibody molecules. J Mol Biol 189: 715-721.
31. Thornton JM, Edwards MS, Taylor WR, Barlow DJ (1986) Location of 'continuous' antigenic determinants in the protruding regions of proteins. EMBO J 5: 409-413.
32. Gershoni JM, Denisova G, Raviv D, Smorodinsky NI, Buyaner D (1993) HIV binding to its receptor creates specific epitopes for the CD4/gp120 complex. FASEB J 7: 1185-1187.
33. Ikeda Y, Toda G, Hashimoto N, Maruyama T, Oka H (1987) Antibody that recognizes conformations of calmodulin in the serum from patient with chronic active hepatitis. Biochem Biophys Res Commun 144: 191-197.
34. Thali M, Moore JP, Furman C, Charles M, Ho DD, et al. (1993) Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J Virol 67: 3978-3988.
35. Bramson JL, Dayball K, Hall JR, Millar JB, Miller M, et al. (2003) Super-activated interferon-regulatory factors can enhance plasmid immunization. Vaccine 21: 1363-1370.
36. Dayball K, Millar J, Miller M, Wan YH, Bramson J (2003) Electroporation enables plasmid vaccines to elicit CD8+ T cell responses in the absence of CD4+ T cells. J Immunol 171: 3379-3384.
37. Boggio K, Nicoletti G, Di Carlo E, Cavallo F, Landuzzi L, et al. (1998) Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice. J Exp Med 188: 589-596.
38. Bonnycastle LL, Mehroke JS, Rashed M, Gong X, Scott JK (1996) Probing the basis of antibody reactivity with a panel of constrained peptide libraries displayed by filamentous phage. J Mol Biol 258: 747-762.
39. Smith GP Phage-Display Vectors and Libraries Based on Filamentous Phage Strain fd-tet http://wwwbioscimissouriedu/smithgp/PhageDisplayWebsite/ PhageDisplayWebsiteIndex.html.
40. Enshell-Seijffers D, Gershoni JM (2002) Phage display selection and analysis of Ab-binding epitopes. Curr Protoc Immunol;chapter 9.
41. Haste Andersen P, Nielsen M, Lund O (2006) Prediction of residues in discontinuous B-cell epitopes using protein 3D structures. Protein Sci 15: 2558-2567.